Results for tag: "Preclinical Brain Imaging"

In the context of Magnetic Resonance Imaging (MRI), the preclinical brain imaging market encompasses the utilization of MRI technology in the visualization, characterization, and quantification of the brain in animal models before clinical application in humans. This field facilitates the in vivo study of neurological disorders, brain development, and neuropharmacology by providing high-resolution images that help researchers understand disease mechanisms and evaluate potential therapeutic interventions. Preclinical MRI systems often feature higher magnetic field strengths compared to those used in clinical settings, resulting in enhanced image quality and spatial resolution crucial for detecting subtle changes in small animal brains. Advancements in MRI technology, such as the development of dedicated animal coils and sophisticated software for image analysis, continue to expand the capabilities of preclinical brain imaging. Some companies active in the preclinical brain imaging market, specializing in MRI technology and related services include Bruker Corporation, which offers a range of high-field MRI systems and accessories for preclinical research. In addition, Aspect Imaging designs compact, high-performance MRI scanners for laboratory use. Another notable company is Agilent Technologies, known for producing advanced imaging equipment and analytics used in various preclinical applications. These companies, among others, contribute to the development and provision of innovative MRI tools that drive forward neuroscientific research and drug development. Show Less Read more